The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 18,588 | 200,000 | SH | SOLE | 1 | 200,000 | 0 | 0 | |
| CERNER CORP | COM | 156782104 | 601 | 6,467 | SH | SOLE | 1 | 6,467 | 0 | 0 | |
| CYRUSONE INC | COM | 23283R100 | 17,944 | 200,000 | SH | SOLE | 1 | 200,000 | 0 | 0 | |
| IHS MARKIT LTD | SHS | G47567105 | 86,398 | 650,000 | SH | SOLE | 1 | 650,000 | 0 | 0 | |
| NUANCE COMMUNICATIONS INC | COM | 67020Y100 | 88,512 | 1,600,000 | SH | SOLE | 1 | 1,600,000 | 0 | 0 | |